Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paraplatin (Carboplatin) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Paraplatin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-20
Patient: male, weighing 59.7 kg (131.2 pounds)
Reactions: Disease Progression
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Start date: 2007-02-21
End date: 2007-06-06
Avastin
Start date: 2007-07-13
End date: 2007-09-27
Taxotere
Indication: non-Small Cell Lung Cancer
Start date: 2007-02-07
End date: 2007-08-23
Gemzar
Indication: non-Small Cell Lung Cancer
Start date: 2007-09-27
End date: 2007-09-27
Paraplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-02-07
End date: 2007-08-23
Other drugs received by patient: Duragesic-100; Duragesic-100; Morphine Sulfate; Duragesic-100; Morphine Sulfate; Duragesic-100; Ativan
|